Gail L. Prater, MSN, CRNP, BC-ADM, CDE
Diabetes Nurse Practitioner
Crescenz VA Medical Center
This activity will bring nurse practitioners up-to-date on the latest available and emerging options in basal insulin therapy, especially biosimilar insulin. To help nurse practitioners address the unmet needs of patients in this area, expert faculty will discuss common barriers to the initiation of and adherence to insulin therapy, strategies to overcome these barriers, especially addressing financial considerations, as well as implementing DMSE/S algorithm of care for improved patient outcomes. A concluding discussion will present evidence-based strategies for integrating the latest in insulin formulations into an overall diabetes management program designed to improve glycemic control; reduce risk of hypoglycemia; and make insulin therapy more convenient, manageable, and effective.
Upon completion of this educational activity, participants will be able to:
This activity is supported by an independent educational grant from Boehringer Ingelheim Pharmaceuticals, Inc. and Lilly USA, LLC
Identify patients with type 2 diabetes mellitus (T2DM) who may benefit from the addition of basal insulin to their management strategy
Articulate the role of the nurse practitioner in implementing diabetes self-management education and support (DMSE/S) algorithm of care
Evaluate the pharmacologic features of traditional and newer basal insulin formulations, especially biosimilar insulins
Assess the evidence for biosimilar insulins with respect to clinical efficacy, safety, and tolerability
Describe how to implement a collaborative team-based approach to patient care for individuals with T2DM
Length of Webinar:
October 26, 2017
October 26, 2018
How to Obtain Credit
To receive credit, participants must complete the online pre-assessment questions, view the webinar in its entirety, and complete the post-assessment and activity evaluation form. Once this is done, participants can request their credit.
This activity is jointly provided by Global Education Group and Physicians Education Resource®, LLC.
This activity has been planned and implemented in accordance with the accreditation Standards of the American Association of Nurse Practitioners (AANP) through joint providership of Global Education Group and PER®. Global Education Group is accredited by the American Association of Nurse Practitioners as an approved provider of nurse practitioner continuing education. Provider number: 1561024. This activity is approved for 1.0 contact hour(s) which includes 0.0 hour(s) of pharmacology.
Activity ID #2335E.
This activity was planned in accordance with AANP CE Standards and Policies.
For information about the approval of this program, please contact Global at 303-395-1782 or firstname.lastname@example.org
Fee Information & Refund/Cancellation Policy
There is no fee for this educational activity.
Disclosure of Conflicts of Interest
Global Education Group (Global) requires instructors, planners, managers and other individuals and their spouse/life partner who are in a position to control the content of this activity to disclose any real or apparent conflict of interest they may have as related to the content of this activity. All identified conflicts of interest are thoroughly vetted by Global for fair balance, scientific objectivity of studies mentioned in the materials or used as the basis for content, and appropriateness of patient care recommendations.
The following contributors have no relevant financial relationships with commercial interests to disclose.
Gail L. Prater, MSN, CRNP, BC-ADM, CDE
Pharmacy Times Continuing Education
Planning Staff—David Heckard; Dipti Desai, PharmD, RPh; Donna Fausak, and Nicole Grassano.
Global Education Group
Kristen Delisi, NP; Lindsay Borvansky; Karen Kaufman; Andrea Funk; Liddy Knight.
Global Education Group and Physicians’ Education Resource®, LLC (PER®) (formerly ArcMesa Educators) strive to provide the highest level of service. However, unforeseen circumstances may necessitate the rescheduling or cancellation of live events, including, but not limited to, webinars, hosted by PER®. PER® reserves the right to cancel an event without notice. PER®will not be responsible for any expenditure incurred due to the cancellation.
Disclosure of Unlabeled Use
This educational activity may contain discussion of published and/or investigational uses of agents that are not indicated by the FDA. Global Education Group (Global) and PER® do not recommend the use of any agent outside of the labeled indications.
The opinions expressed in the educational activity are those of the faculty and do not necessarily represent the views of any organization associated with this activity. Please refer to the official prescribing information for each product for discussion of approved indications, contraindications, and warnings.
Participants have an implied responsibility to use the newly acquired information to enhance patient outcomes and their own professional development. The information presented in this activity is not meant to serve as a guideline for patient management. Any procedures, medications, or other courses of diagnosis or treatment discussed in this activity should not be used by clinicians without evaluation of patient conditions and possible contraindications on dangers in use, review of any applicable manufacturer's product information, and comparison with recommendations of other authorities.
Required: Windows® 7, Vista, XP, 2003 Server or 2000
Required: Mac OS® X 10.4.11 (Tiger®) or newer
For questions about this Internet CPE activity, please contact: email@example.com